$72.23+60.90% · 3M
Moving avg
1W+0.32%
1M+1.22%
3M+60.90%
6M+13.84%
YTD+21.09%
1Y+36.72%
3Y-14.83%
5Y-37.72%
52-week range
$43.20100% of range$72.16
Company health
Value0/6
Growth2/6
Profitability4/6
Health5/6
Dividend2/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (549%)
- Revenue compounding 12% a year
Risks
- Richly valued at 101.1x earnings
Key statistics
Valuation
Market cap
$11.31B
Enterprise value
$11.32B
P/E ratio (TTM)
101.14x
P/S ratio (TTM)
9.29x
EV/EBITDA
43.89x
Per share & returns
EPS (TTM)
$0.70
Dividend yield
0.45%
Beta (1Y)
1.29
30-day change
+1.22%
Trading
Volume (24h)
2.33M
Previous close
$72.15
Shares outstanding
156.57M
About Bio-Techne Corporation
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
TECH
Bio-Techne Corporation is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker TECH.
Frequently asked questions
What is Bio-Techne Corporation's market cap?
Bio-Techne Corporation (TECH) has a market capitalization of $11.31B.
What is Bio-Techne Corporation's P/E ratio?
Bio-Techne Corporation trades at a price-to-earnings (P/E) ratio of 101.14.
What exchange does TECH trade on?
TECH trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.92B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.41B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.93B cap